UPOSMAY Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for UPOSMAY with the United States Patent and Trademark Office. The USPTO has given the UPOSMAY trademark a serial number of 79255637. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 7, 2024. This trademark is owned by Glaxo Group Limited. The UPOSMAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
uposmay

General Information

Serial Number79255637
Word MarkUPOSMAY
Filing DateThursday, March 7, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, October 7, 2024
Registration Number5980267
Registration DateTuesday, February 11, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, October 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressGB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressGB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressGB

Trademark Events

Event DateEvent Description
Wednesday, April 3, 2019ASSIGNED TO EXAMINER
Thursday, March 28, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, April 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 9, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, April 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 30, 2019REFUSAL PROCESSED BY MPU
Wednesday, May 1, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 17, 2019REFUSAL PROCESSED BY IB
Friday, July 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 18, 2019ASSIGNED TO LIE
Thursday, July 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 19, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, September 6, 2019NON-FINAL ACTION WRITTEN
Friday, September 6, 2019NON-FINAL ACTION E-MAILED
Friday, October 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 21, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, October 21, 2019EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 22, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, October 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 24, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 26, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 26, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, June 2, 2020FINAL DISPOSITION PROCESSED
Tuesday, June 2, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 11, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

uposmay pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological